King's College London

Research portal

Correlates of hypersomnia in depression: The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

Research output: Contribution to journalArticle

Standard

Correlates of hypersomnia in depression : The implications of hypersomnia in the context of major depression: Results from a large, international, observational study. / Young, Allan; Angst, J; Vieta, Eduard; Bowden, C L; Murru, Andrea; Barbuti, Margherita.

In: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 14.02.2019.

Research output: Contribution to journalArticle

Harvard

Young, A, Angst, J, Vieta, E, Bowden, CL, Murru, A & Barbuti, M 2019, 'Correlates of hypersomnia in depression: The implications of hypersomnia in the context of major depression: Results from a large, international, observational study', European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

APA

Young, A., Angst, J., Vieta, E., Bowden, C. L., Murru, A., & Barbuti, M. (Accepted/In press). Correlates of hypersomnia in depression: The implications of hypersomnia in the context of major depression: Results from a large, international, observational study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

Vancouver

Young A, Angst J, Vieta E, Bowden CL, Murru A, Barbuti M. Correlates of hypersomnia in depression: The implications of hypersomnia in the context of major depression: Results from a large, international, observational study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2019 Feb 14.

Author

Young, Allan ; Angst, J ; Vieta, Eduard ; Bowden, C L ; Murru, Andrea ; Barbuti, Margherita. / Correlates of hypersomnia in depression : The implications of hypersomnia in the context of major depression: Results from a large, international, observational study. In: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2019.

Bibtex Download

@article{aec26648062a413e9a5b27712d0c1b7f,
title = "Correlates of hypersomnia in depression: The implications of hypersomnia in the context of major depression: Results from a large, international, observational study",
abstract = "According to the DSM-5, “reduction in the need for sleep” is the only sleep-related criteria for mixed features in depressive episodes. We aimed at studying the prevalence, clinical correlates and the role of hypersomnia in a sample of acutely depressed patients. Secondarily, we factors significantly increasing the odds of hypersomnia were studied. We conducted a post-hoc analysis of the BRIDGE-II-Mix study. Variables were compared between patients with hypersomnia (SLEEP+) and with insomnia (SLEEP-) with standard bivariate tests. A stepwise backward logistic regression model was performed with SLEEP+ as dependent variable. A total of 2514 subjects were dichotomized into SLEEP+ (n=423, 16.8%) and SLEEP- (n=2091, 83.2%). SLEEP+ had significant higher rates of obese BMI (p<0.001), BD diagnosis (p=0.027), severe BD (p<0.001), lifetime suicide attempts (p<0.001), lower age at first depression (p=0.004) than SLEEP-. Also, SLEEP+ had significantly poorer response to antidepressants (AD) such as (hypo)manic switches, AD resistance, affective lability, or irritability (all 0<0.005). Moreover, SLEEP+ had significantly higher rates of mixed-state specifiers than SLEEP- (all 0<0.006). A significant contribution to hypersomnia in our regression model was driven by metabolic-related features, such as “current bulimia” (OR=4.21) and “overweight/obese BMI (OR=1.42)”. Globally, hypersomnia is associated with poor outcome in acute depression. Hypersomnia is strongly associated with mixed features and bipolarity. Metabolic aspects could influence the expression of hypersomnia, worsening the overall clinical outcome. Along with commonly used screening tools, detection of hypersomnia has potential, costless discriminative validity in the differential diagnosis unipolar and bipolar depression. ",
keywords = "major depression, bipolar depression, mixed features, hypersomnia, comorbidity, screening-",
author = "Allan Young and J Angst and Eduard Vieta and Bowden, {C L} and Andrea Murru and Margherita Barbuti",
year = "2019",
month = feb,
day = "14",
language = "English",
journal = "European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology",
issn = "0924-977X",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Correlates of hypersomnia in depression

T2 - The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

AU - Young, Allan

AU - Angst, J

AU - Vieta, Eduard

AU - Bowden, C L

AU - Murru, Andrea

AU - Barbuti, Margherita

PY - 2019/2/14

Y1 - 2019/2/14

N2 - According to the DSM-5, “reduction in the need for sleep” is the only sleep-related criteria for mixed features in depressive episodes. We aimed at studying the prevalence, clinical correlates and the role of hypersomnia in a sample of acutely depressed patients. Secondarily, we factors significantly increasing the odds of hypersomnia were studied. We conducted a post-hoc analysis of the BRIDGE-II-Mix study. Variables were compared between patients with hypersomnia (SLEEP+) and with insomnia (SLEEP-) with standard bivariate tests. A stepwise backward logistic regression model was performed with SLEEP+ as dependent variable. A total of 2514 subjects were dichotomized into SLEEP+ (n=423, 16.8%) and SLEEP- (n=2091, 83.2%). SLEEP+ had significant higher rates of obese BMI (p<0.001), BD diagnosis (p=0.027), severe BD (p<0.001), lifetime suicide attempts (p<0.001), lower age at first depression (p=0.004) than SLEEP-. Also, SLEEP+ had significantly poorer response to antidepressants (AD) such as (hypo)manic switches, AD resistance, affective lability, or irritability (all 0<0.005). Moreover, SLEEP+ had significantly higher rates of mixed-state specifiers than SLEEP- (all 0<0.006). A significant contribution to hypersomnia in our regression model was driven by metabolic-related features, such as “current bulimia” (OR=4.21) and “overweight/obese BMI (OR=1.42)”. Globally, hypersomnia is associated with poor outcome in acute depression. Hypersomnia is strongly associated with mixed features and bipolarity. Metabolic aspects could influence the expression of hypersomnia, worsening the overall clinical outcome. Along with commonly used screening tools, detection of hypersomnia has potential, costless discriminative validity in the differential diagnosis unipolar and bipolar depression.

AB - According to the DSM-5, “reduction in the need for sleep” is the only sleep-related criteria for mixed features in depressive episodes. We aimed at studying the prevalence, clinical correlates and the role of hypersomnia in a sample of acutely depressed patients. Secondarily, we factors significantly increasing the odds of hypersomnia were studied. We conducted a post-hoc analysis of the BRIDGE-II-Mix study. Variables were compared between patients with hypersomnia (SLEEP+) and with insomnia (SLEEP-) with standard bivariate tests. A stepwise backward logistic regression model was performed with SLEEP+ as dependent variable. A total of 2514 subjects were dichotomized into SLEEP+ (n=423, 16.8%) and SLEEP- (n=2091, 83.2%). SLEEP+ had significant higher rates of obese BMI (p<0.001), BD diagnosis (p=0.027), severe BD (p<0.001), lifetime suicide attempts (p<0.001), lower age at first depression (p=0.004) than SLEEP-. Also, SLEEP+ had significantly poorer response to antidepressants (AD) such as (hypo)manic switches, AD resistance, affective lability, or irritability (all 0<0.005). Moreover, SLEEP+ had significantly higher rates of mixed-state specifiers than SLEEP- (all 0<0.006). A significant contribution to hypersomnia in our regression model was driven by metabolic-related features, such as “current bulimia” (OR=4.21) and “overweight/obese BMI (OR=1.42)”. Globally, hypersomnia is associated with poor outcome in acute depression. Hypersomnia is strongly associated with mixed features and bipolarity. Metabolic aspects could influence the expression of hypersomnia, worsening the overall clinical outcome. Along with commonly used screening tools, detection of hypersomnia has potential, costless discriminative validity in the differential diagnosis unipolar and bipolar depression.

KW - major depression, bipolar depression, mixed features, hypersomnia, comorbidity, screening-

M3 - Article

JO - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

JF - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

SN - 0924-977X

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454